Contract Formulation Company Profile - Lyophilization Services of New England

Lyophilization Services of New England, Inc.
Lyophilization Services of New England, Inc.

Headquarters
Manchester, NH

Location(s)
Manchester, NH

Years in Drug Formulation
10 Years

Home

Areas of research
	Small Molecule			Biological			Other

Drug Formulation Services Offered
•	Analytical method development	•	Bioavailability enhancement
•	Compatibility studies of active ingredients	•	Dosage form selection
•	Excipient compatibility	•	Formulation optimization
•	Formulation stress testing	•	in silico studies
•	Manufacture of clinical supplies		Novel delivery system
•	Packaging compatibility assessment	•	Particle size reduction
•	Preclinical studies	•	Solubilizing water-insoluble drugs
	Stability studies		Taste masking/flavorings

Other Services Offered
	Disease Research		Target Identification
	Lead Identification		Early Safety Tests
	Lead Optimization	•	Pre-clinical Studies
	IND Submission		Clinical Trials
	NDA Submission		Post-marketing Studies
	OTHER

Types of Drugs
•	Generics		•	Prescription		•	OTC

Dosage Forms
	Capsules		Implantable
	Inhalation	•	Injectible
	Oral	•	Parenteral
•	Peptide and Protein		Tablets
•	Topical		OTHER

Company’s role in drug discovery and developmnet
Lyophilization Services of New England, Inc. (LSNE) has provided CGMP contract manufacturing services since 1997. LSNE offers process development, aseptic and non-aseptic liquid filling into vials and custom containers, as well as dose or bulk lyophilization services to the biotechnology and pharmaceutical industries. LSNE’s three integrated manufacturing facilities and combined processing capacity make it one of the industries leading FDA inspected fill/finish providers. With 2,000 total sq. ft. of shelf space capacity in 19 lyophilization units, as well as 17 aseptic/non-aseptic processing suites, LSNE continues to offer quality consciousness, pre-clinical to commercial scale contract manufacturing services.